Details.
Conference call with Aaron Fletcher, focused on therapeutics in development for COVID-19 and individual long and short opportunities. The discussion covers opportunities created by indiscriminate selling, short opportunities within medtech, services and areas of biotech with excessive COVID-19 hype, and selected biotech companies including APTO, RETA, QURE, IOVA, RGNX and FGEN.